-
Je něco špatně v tomto záznamu ?
Sex-specific interaction between APOE and APOA5 variants and determination of plasma lipid levels
J.A. Hubáček, V. Lánská, Z. Škodová, V. Adámková, R. Poledne
Jazyk angličtina Země Velká Británie
NLK
ProQuest Central
od 2000-01-01 do Před 1 rokem
Open Access Digital Library
od 1998-01-01
Medline Complete (EBSCOhost)
od 1998-01-01 do 2015-12-31
Health & Medicine (ProQuest)
od 2000-01-01 do Před 1 rokem
- MeSH
- alely MeSH
- apolipoproteiny A genetika MeSH
- apolipoproteiny E genetika MeSH
- dospělí MeSH
- financování organizované MeSH
- genetická variace MeSH
- genotyp MeSH
- haplotypy MeSH
- kohortové studie MeSH
- lidé středního věku MeSH
- lidé MeSH
- lipidy krev MeSH
- pohlavní dimorfismus MeSH
- polymorfismus genetický MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
The APOA5 and APOE genes play an important role in determination of plasma levels of triglycerides (TG) and total cholesterol (TC). We have analyzed APOA5 (T-1131>C and Ser19>Trp) and APOE (e2/e3/e4) variants in 2500 representatively selected Caucasians (1168 men, 1332 women). In female subjects (but not in male) an association between APOE polymorphism and TC was observed on the background of the common APOA5 haplotype (TT-1131/SerSer19) - APOE2 carriers have the lowest (5.12 (1.15) mmol/l) and the APOE4 carriers have the highest (6.05 (1.06) mmol/l) levels of plasma TC (P<0.001). If at least one APOA5 C-1131 or Trp19 allele was present, APOE exhibits no significant effect on plasma TC. APOA5 did not affect plasma TG levels, if APOE4 allele was present. In the presence of APOE2 or APOE3, carriers of the APOA5 alleles, C-1131 and/or Trp19, have higher TG levels (1.64 (1.05) mmol/l) than others (1.37 (0.75) mmol/l) (P<0.01). In male subjects, the same, but non-significant trend was observed. In female subjects, we have detected an interaction between APOE and APOA5 variants and plasma lipid levels.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10025577
- 003
- CZ-PrNML
- 005
- 20120202233953.0
- 008
- 101014s2008 xxk e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Hubáček, Jaroslav, $d 1966- $7 nlk20050169367
- 245 10
- $a Sex-specific interaction between APOE and APOA5 variants and determination of plasma lipid levels / $c J.A. Hubáček, V. Lánská, Z. Škodová, V. Adámková, R. Poledne
- 314 __
- $a Cardiovascular Research Centre, Prague, Czech Republic. jaroslav.hubacek@medicon.cz
- 520 9_
- $a The APOA5 and APOE genes play an important role in determination of plasma levels of triglycerides (TG) and total cholesterol (TC). We have analyzed APOA5 (T-1131>C and Ser19>Trp) and APOE (e2/e3/e4) variants in 2500 representatively selected Caucasians (1168 men, 1332 women). In female subjects (but not in male) an association between APOE polymorphism and TC was observed on the background of the common APOA5 haplotype (TT-1131/SerSer19) - APOE2 carriers have the lowest (5.12 (1.15) mmol/l) and the APOE4 carriers have the highest (6.05 (1.06) mmol/l) levels of plasma TC (P<0.001). If at least one APOA5 C-1131 or Trp19 allele was present, APOE exhibits no significant effect on plasma TC. APOA5 did not affect plasma TG levels, if APOE4 allele was present. In the presence of APOE2 or APOE3, carriers of the APOA5 alleles, C-1131 and/or Trp19, have higher TG levels (1.64 (1.05) mmol/l) than others (1.37 (0.75) mmol/l) (P<0.01). In male subjects, the same, but non-significant trend was observed. In female subjects, we have detected an interaction between APOE and APOA5 variants and plasma lipid levels.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a alely $7 D000483
- 650 _2
- $a apolipoproteiny A $x genetika $7 D001054
- 650 _2
- $a apolipoproteiny E $x genetika $7 D001057
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a genetická variace $7 D014644
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a haplotypy $7 D006239
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lipidy $x krev $7 D008055
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a polymorfismus genetický $7 D011110
- 650 _2
- $a pohlavní dimorfismus $7 D012727
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Lánská, Věra $7 xx0062305
- 700 1_
- $a Škodová, Zdenka $7 xx0153069
- 700 1_
- $a Adámková, Věra, $d 1954- $7 jx20050329003
- 700 1_
- $a Poledne, Rudolf, $d 1940- $7 nlk20040147088
- 773 0_
- $w MED00005019 $t European journal of human genetics $g Roč. 16, č. 1 (2008), s. 135-138 $x 1018-4813
- 910 __
- $a ABA008 $b x $y 7
- 990 __
- $a 20101020120837 $b ABA008
- 991 __
- $a 20120202234201 $b ABA008
- 999 __
- $a ok $b bmc $g 800545 $s 665414
- BAS __
- $a 3
- BMC __
- $a 2008 $b 16 $c 1 $d 135-138 $i 1018-4813 $m European journal of human genetics $n Eur J Hum Genet $x MED00005019
- LZP __
- $a 2010-B/jtme